Position in MRK
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$9,724,880
+$568,406 QoQ
Shares Held
75,680
-0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#752
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. MRK ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,724,880 | 75,680 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $9,156,474 | 76,120 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $7,970,287 | 75,720 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,434,997 | 76,671 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,237,333 | 78,794 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $7,330,340 | 81,666 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,188,795 | 82,316 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,537,563 | 83,987 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,896,200 | 79,937 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,489,893 | 79,499 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $9,071,663 | 83,211 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,552,571 | 83,075 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,687,105 | 83,951 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $8,990,061 | 84,501 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $9,377,715 | 84,522 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $7,341,988 | 85,253 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $7,772,516 | 85,253 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $6,963,993 | 84,875 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $6,537,162 | 85,297 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,442,259 | 85,771 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $6,662,633 | 85,671 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,627,507 | 85,971 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $7,025,062 | 85,881 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $7,314,451 | 88,179 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $6,923,048 | 89,526 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $6,888,820 | 89,535 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||